期刊文献+

《药物流行病学研究方法学指南》团体标准的制定过程 被引量:2

Developing Process of ‘Guide on Methodological Standards in Pharmacoepidemiology’
下载PDF
导出
摘要 药物流行病学是指采用流行病学的研究方法研究药物及医疗产品在人群中的使用情况和效果,从而评价其安全性和有效性的一门学科。规范化的开展药物流行病学研究是上述工作的基础,因此,中国药学会药物流行病学专业委员会在系统综述国内外药物流行病学研究方法学标准和指南的基础上,结合我国的医疗卫生实践,咨询多学科专家意见,制定出符合我国国情的药物流行病学研究方法学指南,并在其基础上提出了团体标准,为政府监管部门、研究机构、药物生产企业等开展药物流行病学研究提供指引和参考。 Pharmacoepidemiology refers to the use of epidemiological research methods to study the application and use of drugs in large populations to evaluate the safety and efficacy of medical products. Therefore, how to standardize pharmacoepidemiology research is the basis of the above work. Based on a systematic review of national and international pharmacoepidemiological methodological standards and guidelines, and in combination with China's medical and health practice and experts ’ opinions, the Professional Committee of Pharmacoepidemiology of Chinese Pharmaceutical Association has developed guidance and group standard for pharmacoepidemiology research methods. The guideline was designed to provide advice and reference for pharmacoepidemiology research by goveniment, regulatory agencies, research institutions, and pharmaceutical manufacturers in China.
作者 胥洋 丁呈怡 卓琳 詹思延 Xu Yang;Ding Chengyi;Zhuo Lin;Zhan Siyan(Department of Epidemiology and Biostatistics,Peking University School of Public Health,Beijing 100191,China;Research Center of Clinical Epidemiology,Peking University Third Hospital)
出处 《药物流行病学杂志》 CAS 2019年第10期631-635,共5页 Chinese Journal of Pharmacoepidemiology
基金 中国科协承接政府转移职能与科技公共服务项目(编号:2016GGFZ002)
关键词 药物流行病学研究 指南制定 方法学 Pharmacoepidemiology research Guideline development Methodology
  • 相关文献

参考文献4

二级参考文献15

  • 1World Health Organization. WHO handbook for guideline development. WHO, 2014.
  • 2Moynihan R, Oxman A, Lavis J, et al. Evidence-informed health policy: Using research to make health systems healthier. Oslo: Norwegian Knowledge Centre for the Health Services. 2006.
  • 3WHO and Rapid Advice Guidelines: History and Future Directions. Available at: http://www.g-i-n.net/conference/past-conferences/10th-conference/monday/10-00-am-to-1-00-pm/norris-62.pdf.
  • 4World Health Organization. Rapid risk assessment of acute public health events, 2012.
  • 5Cunha A. Transparent development of WHO rapid advice guidelines: A useful approach. PLoS Med, 2007, 4(7): e245.
  • 6Khangura S, Konnyu K, Cushman R, et al. Evidence summaries: the evolution of a rapid review approach. Syst Rev, 2012, 1(1): 10.
  • 7Watt A, Cameron A, Sturm L, et al. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care, 2008, 24(2): 133-139.
  • 8Schünemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO Rapid Advice Guidelines. PLoS Med, 2007, 4(5): e119.
  • 9Schünemann HJ, Hill S, Kakad M, et al. WHO Rapid Advice Guidelines for the pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis, 2007, 7(1): 21-31.
  • 10World Health Organization. Personal protective equipment in the context of filovirus disease outbreak response rapid advice guideline: summary of the recommendations, 2014.

共引文献6735

同被引文献9

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部